Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
O-I Glass | OI | Mar 27, 2024 | 16.19 | +3.72 |
Oak Valley Bancorp | OVLY | Mar 27, 2024 | 24.71 | +3.82 |
Oak Woods Acquisition | OAKU | Mar 27, 2024 | 10.76 | 0.00 |
Oaktree Capital A Pref | OAK-A | Mar 27, 2024 | 23.93 | +0.10 |
Oaktree Capital Group B Pref | OAK-B | Mar 27, 2024 | 23.40 | +0.17 |
Oaktree Specialty | OCSL | Mar 27, 2024 | 19.50 | +0.46 |
Oasis Petroleum | CHRD | Mar 27, 2024 | 175.79 | +1.52 |
Oatly ADR | OTLY | Mar 27, 2024 | 1.09 | 0.00 |
Oblong | OBLG | Mar 27, 2024 | 0.14 | +8.24 |
OCA Acquisition A | OCAX | Mar 27, 2024 | 10.82 | -0.37 |
Occidental Petroleum | OXY | Mar 27, 2024 | 64.20 | +1.39 |
Ocean Biomedical | OCEA | Mar 27, 2024 | 4.06 | -0.25 |
Ocean Power Technologies | OPTT | Mar 27, 2024 | 0.27 | +0.98 |
Oceaneering International | OII | Mar 27, 2024 | 23.33 | +2.15 |
OceanFirst Financial | OCFC | Mar 27, 2024 | 16.10 | +4.27 |
OceanFirst Pref | OCFCP | Mar 27, 2024 | 24.79 | +1.14 |
OceanPal | OP | Mar 27, 2024 | 2.78 | +2.21 |
Ocugen | OCGN | Mar 27, 2024 | 1.78 | +2.89 |
Ocular Therapeutix | OCUL | Mar 27, 2024 | 9.31 | +1.20 |
Oculis | OCS | Mar 27, 2024 | 11.91 | +2.58 |
Ocuphire Pharma | OCUP | Mar 27, 2024 | 2.02 | -0.49 |
Ocwen Financial | OCN | Mar 27, 2024 | 26.77 | +2.29 |
Oddity Tech | ODD | Mar 27, 2024 | 42.98 | +2.87 |
Odyssey Marine Exploration | OMEX | Mar 27, 2024 | 4.01 | +4.16 |
Offerpad Solutions A | OPAD | Mar 27, 2024 | 8.54 | +4.27 |
Office Properties | OPI | Mar 27, 2024 | 2.09 | +8.29 |
OFG Bancorp | OFG | Mar 27, 2024 | 36.46 | +2.62 |
OFS Capital | OFS | Mar 27, 2024 | 9.78 | -0.05 |
OFS Credit | OCCI | Mar 27, 2024 | 7.15 | +2.45 |
OFS Credit C Pref | OCCIO | Mar 27, 2024 | 23.88 | +1.06 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.